CCM Research Update: CureDriver, AI, and REC-994

Join us for our CCM research update with Alliance to Cure CEO, Connie Lee, PsyD, and Chief Scientific Officer, Angela Glading, PhD. They’ll cover the latest progress toward treatments for cerebral cavernous malformation (CCM) and what it means for patients and families. Everyone is welcome, whether you’re newly diagnosed or have followed CCM research for years.
Flyer for Alliance to Cure’s webinar “CCM Research Update: CureDriver, AI, and REC-994” with CEO Connie Lee, PsyD, and Chief Scientific Officer Angela Glading, PhD. Thursday, Nov. 19, 2026, 7 pm ET / 4 pm PT. The recording will be posted on YouTube.